ANL
Price
$1.44
Change
-$0.03 (-2.04%)
Updated
Jul 25 closing price
Capitalization
53.14M
11 days until earnings call
JAZZ
Price
$118.23
Change
+$0.22 (+0.19%)
Updated
Jul 25 closing price
Capitalization
7.15B
9 days until earnings call
Interact to see
Advertisement

ANL vs JAZZ

Header iconANL vs JAZZ Comparison
Open Charts ANL vs JAZZBanner chart's image
Adlai Nortye
Price$1.44
Change-$0.03 (-2.04%)
Volume$6.95K
Capitalization53.14M
Jazz Pharmaceuticals
Price$118.23
Change+$0.22 (+0.19%)
Volume$549.7K
Capitalization7.15B
ANL vs JAZZ Comparison Chart in %
Loading...
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. JAZZ commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a StrongBuy and JAZZ is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ANL: $1.44 vs. JAZZ: $118.23)
Brand notoriety: ANL and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 68% vs. JAZZ: 80%
Market capitalization -- ANL: $53.14M vs. JAZZ: $7.15B
ANL [@Biotechnology] is valued at $53.14M. JAZZ’s [@Biotechnology] market capitalization is $7.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, ANL is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 3 TA indicator(s) are bullish while JAZZ’s TA Score has 6 bullish TA indicator(s).

  • ANL’s TA Score: 3 bullish, 2 bearish.
  • JAZZ’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than ANL.

Price Growth

ANL (@Biotechnology) experienced а -4.00% price change this week, while JAZZ (@Biotechnology) price change was +4.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

ANL is expected to report earnings on Aug 07, 2025.

JAZZ is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($7.15B) has a higher market cap than ANL($53.1M). JAZZ YTD gains are higher at: -3.995 vs. ANL (-46.373). JAZZ has higher annual earnings (EBITDA): 1.25B vs. ANL (-49.89M). JAZZ has more cash in the bank: 2.57B vs. ANL (98M). ANL has less debt than JAZZ: ANL (39.5M) vs JAZZ (5.42B). JAZZ has higher revenues than ANL: JAZZ (4.07B) vs ANL (5M).
ANLJAZZANL / JAZZ
Capitalization53.1M7.15B1%
EBITDA-49.89M1.25B-4%
Gain YTD-46.373-3.9951,161%
P/E RatioN/A16.06-
Revenue5M4.07B0%
Total Cash98M2.57B4%
Total Debt39.5M5.42B1%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
61
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
8

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANLJAZZ
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 9 days ago
56%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVIR3.900.16
+4.28%
Atea Pharmaceuticals
GIFLF13.90N/A
N/A
Grifols Sa
TKCBF5.99N/A
N/A
Tokai Carbon Company Ltd.
PRE8.06N/A
N/A
Prenetics Global Limited
BPKKF5.70N/A
N/A
BP Castrol KK

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and FGHQF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and FGHQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
-2.04%
FGHQF - ANL
25%
Poorly correlated
N/A
JAZZ - ANL
22%
Poorly correlated
+0.19%
NVCT - ANL
21%
Poorly correlated
+0.65%
VCEL - ANL
21%
Poorly correlated
+1.01%
MDXG - ANL
21%
Poorly correlated
-1.17%
More